Obstructive airway diseases : role of lipid mediators

Obstructive Airway Diseases: Epidemiology, Etiology, and Therapeutic Options Abhijit Ray Lipids: Reservoir of Drug Targets Abhijit Ray and Punit Kumar Srivastava Phospholipase A2 as a Potential Drug Target for Airway Disorders Yoshitaka Taketomi and Makoto Murakami 5-Lipoxygenase Pathway: A Validated Route to Drug Discovery Carlo Pergola and Oliver Werz Leukotriene Receptor Antagonists and FLAP Inhibitors Suman Gupta and Sanjay Malhotra EETs and Oxo-ETE in Airway Diseases Jun Yang, Hua Dong, and Bruce D. Hammock The Eosinophil Chemoattractant 5-Oxo-ETE William S. Powell and Joshua Rokach Cyclooxygenases and Prostaglandin Receptors Jitesh P. Iyer, Jitendra Anant Sattigeri, and Sunanda Ghosh Dastidar Proresolution Mediators of Inflammation in Airway Diseases: Resolvins Pave New Directions Bruce D. Levy and Charles N. Serhan Platelet-Activating Factor Antagonist Therapy for Airway Disorders Punit Kumar Srivastava, Kent E. Pinkerton, and Rishabh Dev Lysophosphatidic Acid in Airway Inflammation Yutong Zhao and Viswanathan Natarajan Sphingolipids in Airway Inflammation Sameer Sharma and Carole A. Oskeritzian Protein Kinase C Isozymes and Airway Inflammation Puneet Chopra, V. Senthil, and Manish Diwan Prospects for PI3 Kinase Signaling Inhibition in Obstructive Airway Diseases Kazuhiro Ito and Nicolas Mercado